SULM – Schweizerische Union für Labormedizin | Union Suisse de Médecine de Laboratoire | Swiss Union of Laboratory Medicine

Summaries Swiss MedLab 2004

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   

A
Antonarakis Stylianos
7PS11 Conserved non-genic sequences

Assmann Gerd
8DS1 Implications of emerging risk factors for therapeutic intervention

^top
B
Blaton Victor
6SS1 Education and Training in Clinical Chemistry in Europe: FESCC initiatives and Lessons from the Experiences.

Blum Stephanie
8PL4 Functional Foods: Probiotics – Microorganisms for health beneficial foods

Bollerup Anne Catherine
7PL3 QM-Systems, focussing on accreditation and ISO

Brand Birgit
6PS23 Haemophilia and infections

Brandes Andrea
6PS32 Transport of dangerous organisms

^top
C
Christen Stephan
8PL3 Reactive oxygen species and ageing

Cullen Paul
7PS12 Automated reporting of multiparametric genetic tests

^top
D
Daniels Geoff
8SV4 Blood grouping by molecular genetics: present and future

Duncan Alexander
6PS22 Disseminated Intravascular Coagulation in Sepsis. New Treatment Modalities

^top
F
Fumic Ksenija
8AS2 FOLLOW-UP OF ENZYME REPLACEMENT THERAPY IN LYSOSOMAL DISEASES

Funke Harald
8DS3 Genetic Risk Factors

^top
G
Guder Walter
7PWAA_A Quality Standards in the Alps-Adria Laboratories

^top
H
Haas Cordula
7PS14 Setup and management of the Swiss DNA database

Hanmin Zhu
6SS4 The rate of bone turnover in the older old persons

Hardy Jean-François
5PL4 Current status of transfusion triggers for red blood cell concentrates

Hächler Herbert
6PS33 Bio-Terror: Swiss Networks and Referencing of Relevant Bacteria at The Swiss National Centre for Anthrax (NANT)

Hess Max
6PL1 Defence Mechanisms Reviewed

Hofmann Esther
7PS32 Reconciliation of physicians needs with laboratory reqiurements

Hong Tai
7SS1 The antithrombotic effect of TMVA, a GPIb binding protein from snake venom

Höpflinger François
8PL1 Ageing and lifestyles - new ageing of new generations

Huber Andreas
7PS24 Economic benefits of Laboratory Medicine

^top
J
Jaggi Rolf
9PL3 New Tools in the Diagnosis of Cancer

Jerin Aleš
8AS5 Role of early inflammatory markers in surgery

^top
K
Kaiser Laurent
6PS34 SARS and other respiratory viruses

Kehrel Beate
6PS24 Platelets as defence cells

Kent Alastair
7PS13 Reporting Genetic Results

Kocna Petr
9AS1 Serology markers in the screening and diagnostics of coeliac disease

Kovac Gustav
7PWAA_C C Harmonising the Curricula of Postgradual Education in Clinical Chemistry and Laboratory Medicine in the Slovak Republic – Lessons Learned and Problems

Kovács Gábor L.
9AS4 Quality issues of immunochemistry assays

^top
L
Lackner Karl
8DS2 New Risk Factors for Cardiovascular Disease

Leibundgut Kurt
9PL2 Molecular pathogenesis in pediatric cancer: the TEL-AML1 chimera in ALL

Lévy Guy
8SV1 Blood products: yesterday, today & tomorrow

^top
M
Mair Johannes
5PL1 Clinical Chances and Limitations of BNP Assay

Margetic Sandra
9AS3 Diagnostic Role of Soluble Serum Transferrin Receptors in Anemias

Matyas Gabor
7SS2 Recent tools for DNA extraction, mutation detection and SNP genotyping

Mesko Brguljan Pika
7PWAA_B Quality Standards in Slovenian Medical Laboratories

Mühlemann Kathrin
6PS13 PROJECT OF THE SWISS NATIONAL FOUNDATION (NRP49) ON ANTIBIOTIC RESISTANCE SURVEILLANCE - SEARCH

Müller Mathias M.
7PL2 Quality and Economics

Müller Hansjakob
9PS12 Hereditary colon cancer: from bedside to bench and back

^top
O
Osterhaus Albert
6PL4 Emerging virus infections in a changing world

^top
R
Recker Franz
9PS13 PSA Screening for Prostate Cancer

Rentsch Katharina
7PS33 Near Patient Drug Monitoring

Risch Lorenz
6SS3 Estimates and measurements of renal function: uses and pitfalls

Rossier Michelle
7PS31 Limits, benefits and pitfalls of POCT and near patient testing

Röthlisberger Benno
7SS4 Tumorcytogenetics

Ruef Christian
6PS11 Nosocomial Infections - The Burning Issues in 2004

^top
S
Sauter Jean-François
7PS22 Experience with the new IVD regulations

Sax Hugo
6PS12 Swiss-NOSO: Swiss nosocomial infection prevalence study (snip)

Schoch Claudia
9PL4 Leukemia: Genetic and Diagnostis Aspects

Senn Marianne
8SV3 Hemovigilance in Switzerland

Stegnar Mojca
9AS2 Activation markers of the haemostatic system in cardiovascular disease

Stelling Marie-José
8SV2 Immunohematological tests (patients and donors)

Stieber Petra
9PL1 Oncological biomarkers - from observation to intervention

Stojanović Nataša
8AS3 Probabilistic kinetic model of slow oxidation of LDL

Straub Rolf
7PS21 Worldwide comparability of measuring results

^top
T
Topic Elizabeta
8AS1 Pharmacogenetic testing in therapy optimization

Troillet Nicolas
6PS14 Surveillance and prevention of surgical site infections

Tsakiris Dimitrios
6PS21 Coagulopathy in sepsis: pathogenesis and laboratory hallmarks

^top
V
Vasen Hans
9PS14 Secundary prevention of hereditary cancer

Vögeli Urs
6PS31 Diagnostics/analysis of dangerous microorganisms

van Pelt Hans
7PS34 POCT in the hospital: What's the point and who cares?

von Bremen Konrade
7PL1 Economic assessment – for the right or for the wrong?

von Eckardstein Arnold
8PL2 Role of the clinical laboratory in diagnosing and monitoring (premature) aging

^top
W
Wang Qian
6SS2 Review of fight against the infectious atypical pneumonia in Guangdong province

Wieland Eberhard
8DS4 Risk Factors of Cardiovascular and Neurodegenerative Diseases: Role of Oxidative Stress

Wüthrich Kurt
6NLL From Hemoglobin to Mad Cow Disease – 35 Years of NMR in Biological and Biomedical Research

^top
Y
Yuan Lu
7SS5 Tree Analysis of Mass Spectral Urine Profiles Discriminates Transitional Cell Carcinoma of the Bladder from Non-cancer Patient

^top
Z
Zanic Grubisic Tihana
8AS4 Role of stress proteins in development of apoptosis

Zwicky Caroline
7PS23 Benefits and costs of Quality: Accreditation of the autologous hematopoietic progenitor cell transplantation program at the Inselspital in Bern, CH.

Sie sind hier | Vous êtes ici:

Agenda

Hämatologie Workshop, 29. März 2017 - Mit Dr. Heinz Diem > mehr

pipette

pipette 01/2017: Hämatologie – WHO Update 2016 | Hématologie – Update OMS 2016

Aktuelle Ausgabe als E-Paper lesen

Jobs

07.11.2016: BMA HF Mikrobiologie (50–100%)